Genetic considerations in the design of a malaria vaccine
Rzepczyk, C.M.
Papua and New Guinea Medical Journal 32(4): 251-258
1989
ISSN/ISBN: 0031-1480 PMID: 2483292 Document Number: 345501
Enormous progress has been made in recent years in understanding the molecular basis of the interaction of peptides, the major histocompatibility complex and the T-cell receptor. Considerable information must still be gathered before a malaria vaccine capable of protecting individuals in endemic areas is available. This review discusses studies pertaining to the research for T epitopes suitable for inclusion in a malaria vaccine in the light of current concepts of the recognition of peptides by T cells.
Document emailed within 1 workday
Related Documents
Amante, F.H.; Crewther, P.E.; Anders, R.F.; Good, M.F. 1997: A cryptic T cell epitope on the apical membrane antigen 1 of Plasmodium chabaudi adami can prime for an anamnestic antibody response: implications for malaria vaccine design Journal of Immunology 159(11): 5535-5544Nakada, S. 1987: New technology of vaccine production--international prospect of the development--subunit vaccine obtained by genetic engineering. b. Genetic engineering method using animal cells Nihon Rinsho. Japanese Journal of Clinical Medicine 45(10): 2326-2332
Nosten, F.; Luxemburger, C.; Kyle, D.E.; Ballou, W.R.; Wittes, J.; Wah, E.; Chongsuphajaisiddhi, T.; Gordon, D.M.; White, N.J.; Sadoff, J.C.; Heppner, D.G. 1996: Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand. Shoklo SPf66 Malaria Vaccine Trial Group Lancet 348(9029): 701-707
Esposito, F.; Gambella, R.; Modiano, D.; Lamizana, L.; Lombardi, S.; Rotigliano, G.; Habluetzel, A. 1991: Waiting for the vaccine: sporozoite vaccine research entails important progress in malaria epidemiology Parassitologia 33(1): 85-91
Boëte, C.; Koella, J.C. 2002: A theoretical approach to predicting the success of genetic manipulation of malaria mosquitoes in malaria control Malaria Journal 1: 3
Elghazali, G.; Esposito, F.; Troye-Blomberg, M. 1995: Comparison of the number of IL-4 and IFN-gamma secreting cells in response to the malaria vaccine candidate antigen Pf155/RESA in two groups of naturally primed individuals living in a malaria endemic area in Burkina Faso Scandinavian Journal of Immunology 42(1): 39-45
Lewis, A.D. 1978: Hospital design considerations Clinical Engineering 6(2): 20-24
Poppe, E.A.; Norrey, C.; Rodon, T. 2005: Design considerations when using semicrystalline engineering polymers Medical Device Technology 16(7): 12-15
Brigham, F.R. 1975: Some quantitative considerations in questionnaire design and analysis Applied Ergonomics 6(2): 90-96
Lonner, J.H. 2004: Patellofemoral arthroplasty: pros, cons, and design considerations Clinical Orthopaedics and Related Research 428: 158-165
Jacobson, T.E. 1987: Periodontal considerations in removable partial denture design Compendium 8(7): 530
Rangert, B.; Sennerby, L.; Meredith, N.; Brunski, J. 1997: Design, maintenance and biomechanical considerations in implant placement Dental Update 24(10): 416-420
Foppa, C. 2009: The "new vaccine" against HIV. Ethical considerations Revue Medicale Suisse 5(222): 2118
Mamotte, N.; Wassenaar, D.; Koen, J.; Essack, Z. 2010: Convergent ethical issues in HIV/AIDS, tuberculosis and malaria vaccine trials in Africa: Report from the WHO/UNAIDS African AIDS Vaccine Programme's Ethics, Law and Human Rights Collaborating Centre consultation, 10-11 February 2009, Durban, South Africa Bmc Medical Ethics 11: 3
Mamotte, N.; Wassenaar, D.; Koen, J.; Essack, Z. 2010: Convergent ethical issues in HIV/AIDS, tuberculosis and malaria vaccine trials in Africa: Report from the WHO/UNAIDS African AIDS Vaccine Programme's Ethics, Law and Human Rights Collaborating Centre consultation, 10-11 February 2009, Durban, South Africa Bmc Medical Ethics 11: 3
Mamotte, N.; Wassenaar, D.; Koen, J.; Essack, Z. 2010: Convergent ethical issues in HIV/AIDS, tuberculosis and malaria vaccine trials in Africa: Report from the WHO/UNAIDS African AIDS Vaccine Programme's Ethics, Law and Human Rights Collaborating Centre consultation, 10-11 February 2009, Durban, South Africa Bmc Medical Ethics 11: 3
Mamotte, N.; Wassenaar, D.; Koen, J.; Essack, Z. 2010: Convergent ethical issues in HIV/AIDS, tuberculosis and malaria vaccine trials in Africa: Report from the WHO/UNAIDS African AIDS Vaccine Programme's Ethics, Law and Human Rights Collaborating Centre consultation, 10-11 February 2009, Durban, South Africa Bmc Medical Ethics 11: 3
Mamotte, N.; Wassenaar, D.; Koen, J.; Essack, Z. 2010: Convergent ethical issues in HIV/AIDS, tuberculosis and malaria vaccine trials in Africa: Report from the WHO/UNAIDS African AIDS Vaccine Programme's Ethics, Law and Human Rights Collaborating Centre consultation, 10-11 February 2009, Durban, South Africa Bmc Medical Ethics 11: 3
Mamotte, N.; Wassenaar, D.; Koen, J.; Essack, Z. 2010: Convergent ethical issues in HIV/AIDS, tuberculosis and malaria vaccine trials in Africa: Report from the WHO/UNAIDS African AIDS Vaccine Programme's Ethics, Law and Human Rights Collaborating Centre consultation, 10-11 February 2009, Durban, South Africa Bmc Medical Ethics 11: 3
Mamotte, N.; Wassenaar, D.; Koen, J.; Essack, Z. 2010: Convergent ethical issues in HIV/AIDS, tuberculosis and malaria vaccine trials in Africa: Report from the WHO/UNAIDS African AIDS Vaccine Programme's Ethics, Law and Human Rights Collaborating Centre consultation, 10-11 February 2009, Durban, South Africa Bmc Medical Ethics 11: 3